"The staff of the NYHC is dedicated to providing relief of pain and suffering to children and adults with chronic migraines, cluster and other types of headaches, post-concussion syndrome, neuralgias, and facial pain. Our headache specialists provide compassionate care and always employ integrative medicine, that is a combination of traditional medicine, as well as functional, complementary and alternative therapies. Many of these complementary therapies and Botox injections help our patients achieve and maintain relief without the need for medications. We also conduct clinical trials and are currently testing transcranial direct current stimulation (tDCS) for the prevention of migraines. This is a very safe and promising treatment."

During the past decade, New York Headache Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York Headache Center" #1 sponsor was "Winston Laboratories" with 2 trials, followed by "Alexza Pharmaceuticals, Inc." with 1 trials sponsored, "ElectroCore INC" with 1 trials sponsored, "MJHS Institute for Innovation in Palliative Care" with 1 trials sponsored and "ProEthic Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Headache Center" #1 collaborator was "New York Headache Center" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "New York Headache Center" are "Episodic Cluster Headache" (2 trials), "Migraine" (2 trials), "Aura" (1 trials), "Migraine Disorders" (1 trials) and "Migraine Headache" (1 trials). Many other conditions were trialed in "New York Headache Center" in a lesser frequency.

Most popular intervention types in "New York Headache Center" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Civamide (Zucapsaicin)" (2 trials), "Inhaled PCZ 10 mg" (1 trials), "Inhaled PCZ 5 mg" (1 trials), "Inhaled PCZ 7.5 mg" (1 trials) and "Inhaled Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Headache Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "New York Headache Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in New York Headache Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New York Headache Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".